Curcumin-Loaded RH60/F127 Mixed Micelles: Characterization, Biopharmaceutical Characters and Anti-Inflammatory Modulation of Airway Inflammation

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Dec 23

PMID 38140051

Authors

Xinli Wang

Yanyan Wang

Tao Tang

Guowei Zhao

Wei Dong

Qiuxiang Li

Xinli Liang

Affiliations

Soon will be listed here.

Abstract

Curcumin's ability to impact chronic inflammatory conditions, such as metabolic syndrome and arthritis, has been widely researched; however, its poor bioavailability limits its clinical application. The present study is focused on the development of curcumin-loaded polymeric nanomicelles as a drug delivery system with anti-inflammatory effects. Curcumin was loaded in PEG-60 hydrogenated castor oil and puronic F127 mixed nanomicelles (Cur-RH60/F127-MMs). Cur-RH60/F127-MMs was prepared using the thin film dispersion method. The morphology and releasing characteristics of nanomicelles were evaluated. The uptake and permeability of Cur-RH60/F127-MMs were investigated using RAW264.7 and Caco-2 cells, and their bioavailability and in vivo/vitro anti-inflammatory activity were also evaluated. The results showed that Cur-RH60/F127-MMs have regular sphericity, possess an average diameter smaller than 20 nm, and high encapsulation efficiency for curcumin (89.43%). Cur-RH60/F127-MMs significantly increased the cumulative release of curcumin in vitro and uptake by cells ( < 0.01). The oral bioavailability of Cur-RH60/F127-MMs was much higher than that of curcumin-active pharmaceutical ingredients (Cur-API) (about 9.24-fold). The treatment of cell lines with Cur-RH60/F127-MMs exerted a significantly stronger anti-inflammatory effect compared to Cur-API. In addition, Cur-RH60/F127-MMs significantly reduced OVA-induced airway hyperresponsiveness and inflammation in an in vivo experimental asthma model. In conclusion, this study reveals the possibility of formulating a new drug delivery system for curcumin, in particular nanosized micellar aqueous dispersion, which could be considered a perspective platform for the application of curcumin in inflammatory diseases of the airways.

References

Zhang M, Tang J, Li Y, Xie Y, Shan H, Chen M . Curcumin attenuates skeletal muscle mitochondrial impairment in COPD rats: PGC-1α/SIRT3 pathway involved. Chem Biol Interact. 2017; 277:168-175. DOI: 10.1016/j.cbi.2017.09.018. View

Liu W, Zhai Y, Heng X, Che F, Chen W, Sun D . Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016; 24(8):694-702. DOI: 10.3109/1061186X.2016.1157883. View

Chen X, Liang X, Zhao G, Zeng Q, Dong W, Ou L . Improvement of the bioavailability of curcumin by a supersaturatable self nanoemulsifying drug delivery system with incorporation of a hydrophilic polymer: in vitro and in vivo characterisation. J Pharm Pharmacol. 2021; 73(5):641-652. DOI: 10.1093/jpp/rgaa073. View

Zhou Y, Hu W, Zhang X, Wang Y, Zhuang W, Li F . Cellular Uptake and Transport Characteristics of FL118 Derivatives in Caco-2 Cell Monolayers. Chem Pharm Bull (Tokyo). 2021; 69(11):1054-1060. DOI: 10.1248/cpb.c21-00467. View

Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M . Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011; 6(12):815-23. DOI: 10.1038/nnano.2011.166. View

Hou Y, Wang H, Zhang F, Sun F, Xin M, Li M . Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin. Int J Nanomedicine. 2019; 14:557-571. PMC: 6333391. DOI: 10.2147/IJN.S191337. View

Jin I, Jo M, Park C, Chung Y, Kim J, Shin D . Physicochemical, Pharmacokinetic, and Toxicity Evaluation of Soluplus Polymeric Micelles Encapsulating Fenbendazole. Pharmaceutics. 2020; 12(10). PMC: 7589096. DOI: 10.3390/pharmaceutics12101000. View

Ahmed T, El-Say K, Ahmed O, Aljaeid B . Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel. Int J Nanomedicine. 2019; 14:5555-5567. PMC: 6662514. DOI: 10.2147/IJN.S213086. View

Subhashini , Chauhan P, Dash D, Paul B, Singh R . Intranasal curcumin ameliorates airway inflammation and obstruction by regulating MAPKinase activation (p38, Erk and JNK) and prostaglandin D2 release in murine model of asthma. Int Immunopharmacol. 2016; 31:200-6. DOI: 10.1016/j.intimp.2015.12.025. View

10.

Xiao L, Zhou Y, Zhang X, Ding Y, Li Q . Transporter-Targeted Bile Acid-Camptothecin Conjugate for Improved Oral Absorption. Chem Pharm Bull (Tokyo). 2019; 67(10):1082-1087. DOI: 10.1248/cpb.c19-00341. View

11.

Jin Y, Wu Z, Li C, Zhou W, Shaw J, Baguley B . Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration. Pharm Res. 2018; 35(1):13. DOI: 10.1007/s11095-017-2340-y. View

12.

Kong Z, Kuo H, Johnson A, Wu L, Chang K . Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells. Int J Mol Sci. 2019; 20(12). PMC: 6628080. DOI: 10.3390/ijms20122918. View

13.

Hu S, Xu Y, Meng L, Huang L, Sun H . Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Exp Ther Med. 2018; 16(2):1266-1272. PMC: 6090267. DOI: 10.3892/etm.2018.6345. View

14.

Dou T, Wang J, Han C, Shao X, Zhang J, Lu W . Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers. Int J Biol Macromol. 2019; 138:791-799. DOI: 10.1016/j.ijbiomac.2019.07.168. View

15.

Lin X, Bai D, Wei Z, Zhang Y, Huang Y, Deng H . Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS One. 2019; 14(5):e0216711. PMC: 6528975. DOI: 10.1371/journal.pone.0216711. View

16.

Jin C, Shelburne C, Li G, Potts E, Riebe K, Sempowski G . Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. J Clin Invest. 2011; 121(3):941-55. PMC: 3049384. DOI: 10.1172/JCI43584. View

17.

Bochner B, Busse W . Allergy and asthma. J Allergy Clin Immunol. 2005; 115(5):953-9. DOI: 10.1016/j.jaci.2005.02.032. View

18.

Guclu O, Doganlar O, Yuksel V, Doganlar Z . FOLFIRI-Mediated Toxicity in Human Aortic Smooth Muscle Cells and Possible Amelioration with Curcumin and Quercetin. Cardiovasc Toxicol. 2019; 20(2):139-154. DOI: 10.1007/s12012-019-09541-w. View

19.

Djukanovic R, Wilson S, Kraft M, Jarjour N, Steel M, Chung K . Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med. 2004; 170(6):583-93. DOI: 10.1164/rccm.200312-1651OC. View

20.

Dash B, Sun X . Eosinophils set DNA traps in allergic asthma. Nat Cell Biol. 2021; 23(10):1057-1059. DOI: 10.1038/s41556-021-00765-z. View